Promising antibody may prove useful against deadly outbreaks La Jolla Institute for Immunology LA JOLLA, USA — New research led by scientists at La...
Vous n'êtes pas connecté
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.
Promising antibody may prove useful against deadly outbreaks La Jolla Institute for Immunology LA JOLLA, USA — New research led by scientists at La...
Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute...
An experimental therapy AHA-1031 significantly reduced the size of treatment-resistant lung cancer tumors in animal models by stimulating an immune...
New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.
Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists at St. Jude Children's Research...
The federal Department of Health and Human Services (HHS) has canceled a $168,000 grant for an exhibit on Dr. Anthony Fauci at the National Museum...
Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects.
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to...
An international team of researchers has uncovered how certain gut cells activate pain signals, which can persist long after the initial cause is...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential...